Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05571514 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis

Study acronym: NUTRANACRE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Eligibility criteria expanded, about 8 words Collaborators shortened, about 4 words Show 1 more changeShow less
    • Collaborators shortened, about 4 words
  2. Re-verified, no change to tracked fieldsv9
  3. Study sites: 6 to 7v8
  4. Site contacts updated at 5 of 6 sitesv7
  5. Primary completion date: Apr 2024 to Nov 2027 Completion date: Apr 2024 to Nov 2028v6 Show 1 more changeShow less
    • Completion date: Apr 2024 to Nov 2028
Show 4 earlier versionsHide 4 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting Study sites: 5 to 6 · Start date changed from estimate of Jun 2023 to May 12, 2023v5 Show 2 more changesShow less
    • Study sites: 5 to 6
    • Start date changed from estimate of Jun 2023 to May 12, 2023
  2. Start date: Mar 2023 to Jun 2023v4
  3. Study sites: 4 to 5v3
  4. Start date: Jan 2023 to Mar 2023v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Post-menopausal osteoporosis and the resulting fractures are an important cause of disability and loss of independence. They also increase the risk of morbidity and mortality. Given potential side effects, hormone replacement therapy is no longer recommended for menopausal women with risk of becoming osteoporotic. The very significant decrease in the use of these treatments is suspected of contributing to a resurgence in the incidence of osteoporotic fractures, particularly in women before the age of 70. There is a need for prevention of osteoporosis.
Trial Details
NCT Number NCT05571514
Lead Sponsor Centre Hospitalier Universitaire de Saint Etienne
Conditions Post Menopausal Osteoporosis
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov